Issue 3, 2019

Using 2-aminobenzimidazole derivatives to inhibit Mycobacterium smegmatis biofilm formation

Abstract

Biofilm formation by mycobacteria can lead to enhanced antibiotic tolerance. Herein, we report on the identification of a series of 2-aminobenzimidazole (2-ABI) derivatives that potently inhibit biofilm formation by Mycobacterium smegmatis.

Graphical abstract: Using 2-aminobenzimidazole derivatives to inhibit Mycobacterium smegmatis biofilm formation

Supplementary files

Article information

Article type
Research Article
Submitted
14 Jan 2019
Accepted
07 Feb 2019
First published
12 Feb 2019

Med. Chem. Commun., 2019,10, 456-459

Using 2-aminobenzimidazole derivatives to inhibit Mycobacterium smegmatis biofilm formation

T. V. Nguyen, M. T. Peszko, R. J. Melander and C. Melander, Med. Chem. Commun., 2019, 10, 456 DOI: 10.1039/C9MD00025A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements